Versant Ventures hires Roche veteran Magni to boost European coverage
This article was originally published in Scrip
Executive Summary
Versant Ventures, a venture capital group with an exclusive early stage life sciences focus and a total of $1.6 billion under management, has appointed Dr Guido Magni, a former global head of medical sciences at Roche, as a venture partner. Based in Versant's new Basel office, Dr Magni, previously a managing director of EuroVentures Inc., a Versant biotechnology incubator, will work alongside Dr Tom Woiwode, formerly Euroventures' chief operating officer.